Evidence map›Paper›PMID 40137561›Full record

ArticleTomography (Ann Arbor, Mich.)2025

Deep Learning-Based Tumor Segmentation of Murine Magnetic Resonance Images of Prostate Cancer Patient-Derived Xenografts.

Satvik Nayak, Henry Salkever, Ernesto Diaz, Avantika Sinha, Nikhil Deveshwar, Madeline Hess, Matthew Gibbons, Sule Sahin, Abhejit Rajagopal, Peder E Z Larson and 1 more

Abstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Satvik NayakDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0009-0009-9139-1783
Henry SalkeverDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.
Ernesto DiazDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-3716-7758
Avantika SinhaDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-9349-6345
Nikhil DeveshwarDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-5516-3769
Madeline HessDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.
Matthew GibbonsDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-4108-6157
Sule SahinDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-7006-4793
Abhejit RajagopalDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.
Peder E Z LarsonDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-4183-3634
Renuka SriramDepartment of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-3505-2479

Funding

TR&D3: Open-Source Tools for Processing Hyperpolarized MR DataP41EB013598 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Daniel B Vigneron · 2011 to 2026
$19.9M
Preclinical imaging characterization and resource development of PDX SCNC prostate cancer murine modelsU24CA253377 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURHANEWICZ, JOHN, PEEHL, DONNA M. · 2020 to 2024
$3.4M
NCI NIH HHS U24 CA253377NCI NIH HHS U24CA253377NIBIB NIH HHS P41 EB013598NIBIB NIH HHS P41EB013598
6 · The paper itself

Abstract

BACKGROUND/

objectiveLongitudinal in vivo studies of murine xenograft models are widely utilized in oncology to study cancer biology and develop therapies. Magnetic resonance imaging (MRI) of these tumors is an invaluable tool for monitoring tumor growth and characterizing the tumors as well.

methodsIn this work, a pipeline for automating the segmentation of xenografts in mouse models was developed. T RESULTS AND

conclusionsThe slice classifier network achieved 90% accuracy in identifying slices containing tumors. Among the various segmentation architectures tested, the dense residual recurrent U-Net achieved the highest performance in kidney tumors. When evaluated across the kidneys, tibia, and liver, this architecture performed the best when trained on all data as compared to training on only data from a single site (and inferring on a multi-site tumor images), achieving a Dice score of 0.924 across the test set.

Indexed as

Deep LearningImage Processing, Computer-AssistedMagnetic Resonance ImagingProstatic NeoplasmsAlgorithmsAnimalsDisease Models, AnimalHeterograftsHumansKidneyLiverMaleMiceTibiadeep learningmagnetic resonance imagingpatient-derived xenograftsprostate cancertumor segmentation

Identifiers

PMID40137561
PMCPMC11946206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.